Literature DB >> 12029619

Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.

Rosa M Pascale1, Maria M Simile, Maria R De Miglio, Maria R Muroni, Diego F Calvisi, Giuseppina Asara, Daniela Casabona, Maddalena Frau, Maria A Seddaiu, Francesco Feo.   

Abstract

Preneoplastic and neoplastic hepatocytes undergo c-Myc up-regulation and overgrowth in rats genetically susceptible to hepatocarcinogenesis, but not in resistant rats. Because c-Myc regulates the pRb-E2F pathway, we evaluated cell cycle gene expression in neoplastic nodules and hepatocellular carcinomas (HCCs), induced by initiation/selection (IS) protocols 40 and 70 weeks after diethylnitrosamine treatment, in susceptible Fisher 344 (F344) rats, and resistant Wistar and Brown Norway (BN) rats. No interstrain differences in gene expression occurred in normal liver. Overexpression of c-myc, Cyclins D1, E, and A, and E2F1 genes, at messenger RNA (mRNA) and protein levels, rise in Cyclin D1-CDK4, Cyclin E-CDK2, and E2F1-DP1 complexes, and pRb hyperphosphorylation occurred in nodules and HCCs of F344 rats. Expression of Cdk4, Cdk2, p16(INK4A), and p27(KIP1) did not change. In nodules and/or HCCs of Wistar and BN rats, low or no increases in c-myc, Cyclins D1, E, and A, and E2F1 expression, and Cyclin-CDKs complex formation were associated with p16(INK4A) overexpression and pRb hypophosphorylation. In conclusion, these results suggest deregulation of G1 and S phases in liver lesions of susceptible rats and block of G1-S transition in lesions of resistant strains, which explains their low progression capacity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029619     DOI: 10.1053/jhep.2002.33682

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  19 in total

1.  S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers.

Authors:  Maria Lauda Tomasi; Ivan Tomasi; Komal Ramani; Rosa Maria Pascale; Jun Xu; Pasquale Giordano; José M Mato; Shelly C Lu
Journal:  Hepatology       Date:  2012-07-12       Impact factor: 17.425

2.  Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.

Authors:  Julio Isael Pérez-Carreón; Cristina López-García; Samia Fattel-Fazenda; Evelia Arce-Popoca; Leticia Alemán-Lazarini; Sergio Hernández-García; Véronique Le Berre; Sergueï Sokol; Jean Marie Francois; Saúl Villa-Treviño
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

3.  SUMOylation regulates cytochrome P450 2E1 expression and activity in alcoholic liver disease.

Authors:  Maria Lauda Tomasi; Komal Ramani; Minjung Ryoo; Carla Cossu; Andrea Floris; Ben J Murray; Ainhoa Iglesias-Ara; Ylenia Spissu; Nirmala Mavila
Journal:  FASEB J       Date:  2018-01-18       Impact factor: 5.191

4.  Id2 leaves the chromatin of the E2F4-p130-controlled c-myc promoter during hepatocyte priming for liver regeneration.

Authors:  José L Rodríguez; Juan Sandoval; Gaetano Serviddio; Juan Sastre; María Morante; Maria-Giulia Perrelli; María L Martínez-Chantar; José Viña; Juan R Viña; José M Mato; Matías A Avila; Luis Franco; Gerardo López-Rodas; Luis Torres
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

5.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Konstantinos Evangelou; Sophia Havaki; Athanassios Kotsinas
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  E2F transcription factors and digestive system malignancies: how much do we know?

Authors:  Athanasios Xanthoulis; Dina G Tiniakos
Journal:  World J Gastroenterol       Date:  2013-06-07       Impact factor: 5.742

7.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

8.  Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.

Authors:  Qi Zhou; Qiang He; Li-Jian Liang
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

9.  Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis.

Authors:  Francesco Feo; Maddalena Frau; Rosa-Maria Pascale
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

Review 10.  Transcription addiction: can we garner the Yin and Yang functions of E2F1 for cancer therapy?

Authors:  P Meng; R Ghosh
Journal:  Cell Death Dis       Date:  2014-08-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.